Additionally, we compared the differences in FYB1 expression between normal and cancer cell lines and found that both mRNA and protein levels of FYB1 in cancer cell lines were higher than in CD34+ HSPC (Supplementary Fig. 2C–E). Here, CD34 is linked to cancer.